iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
February 27, 2024 09:05 ET
|
iCAD, Inc.
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably...
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
February 27, 2024 08:05 ET
|
iCAD, Inc.
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect...
iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 06, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Feb. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect...
iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member
January 30, 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Jan. 30, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect...
Digital Breast Tomosynthesis (DBT) Equipment Market Share to Surpass USD 6.83 billion by 2030 | Analysis by Persistence Market Research
January 22, 2024 07:56 ET
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global digital breast tomosynthesis (DBT) equipment market is expected to grow at a rate of 13.9%, reaching a value of US$6.83 billion by 2030 from...
Comprise named top agency in several business, PR and marketing awards programs
December 19, 2023 06:00 ET
|
Comprise
Boulder, Colo., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Comprise® solidified its status as a leading communications agency delivering integrated public relations and digital marketing services with the...
iCAD Expands Executive Sales Leadership Team as Business Grows
December 18, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Dec. 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced the expansion of its sales...
Global Artificial Intelligence In Precision Medicine Market Size To Worth USD 5.79 Billion By 2032 | CAGR of 16.3%
December 06, 2023 09:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The Global Artificial Intelligence In Precision Medicine Market Size is to Grow from USD 1.28 Billion in 2022 to USD 5.79 Billion by 2032,...
Brachytherapy Market Size Worth USD 670.92 Billion in 2032 | Emergen Research
December 04, 2023 09:10 ET
|
Emergen Research
Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global brachytherapy market is projected to be worth USD 670.92 Million by 2032, according to a current analysis by Emergen Research. The...
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
November 28, 2023 08:00 ET
|
iCAD, Inc.
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized...